A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain - Trial NCT06125795
Access comprehensive clinical trial information for NCT06125795 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie and is currently Recruiting. The study focuses on Chronic Lymphocytic Leukemia. Target enrollment is 132 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
AbbVie
Timeline & Enrollment
N/A
Nov 06, 2023
Apr 30, 2025
Primary Outcome
Change in Participant Functioning Measured Using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) with the EORTC Chronic Lymphocytic Leukemia 17 (EORTC-CLL17) Supplement,Change in Participant Health-related Quality of Life (HRQoL)Measured Using the EORTC QLQ-C30 with the EORTC-CLL17 Supplement
Summary
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Since in
 most cases CLL remains an incurable disease, the goals of therapy are to improve quality of
 life and to prolong survival. This study will evaluate the participant's related outcomes and
 experience of CLL in adult participants who are treated in the Spain.
 
 Study participants will receive oral treatments for CLL as prescribed by their study doctor
 in accordance with approved local label. Adult participants prescribed various treatments
 will be enrolled. Around 132 participants will be enrolled in the study in sites in Spain.
 
 Participants will receive oral treatments for CLL according to the approved local label. The
 overall study duration will be 18 months.
 
 There is expected to be no additional burden for participants in this trial. All study visits
 will occur during routine clinical practice.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06125795
Non-Device Trial